STATEMENT OF CONTRIBUTION
Y.L. Lau conceptualized the study. Y.L. Lau, M. Peiris, W. Tu, D. Leung,
J.S. Rosa Duque, and X. Wang designed the study. Y.L. Lau led the
acquisition of funding. Y.L. Lau, W. Tu, and M. Peiris supervised the
project. S.M. Chan, D. Leung, X. Mu, S.M.S. Cheng, I.Y.S. Tam, and
J.H.Y. Lam led the study administrative procedures. W.H.S. Wong provided
software support. S.M. Chan, and W.H.S. Wong contributed to recruitment
of participants. Y.L. Lau and J.S. Rosa Duque provided study-related
clinical assessments and follow-up. D. Leung, S.M. Chan, C.H. Cheang,
J.H.Y. Lam, J.S. Rosa Duque, and Y.L. Lau collected safety data. S.M.S.
Cheng, S. Chaothai, L.C.H. Tsang, and M. Peiris developed and performed
S-RBD IgG, and sVNT. X. Mu, Y. Zhang, M. Wang, W. Zhang, Y. Chung,
H.H.W. Wong, A.M.T. Lee, W.Y. Li, X. Wang, and W. Tu developed and
performed the T cell assays. D. Leung, T.S.S. Lee, and J.H.Y. Lam
curated and analyzed the data. D. Leung and J.H.Y. Lam visualized the
data. D. Leung, X. Mu, S.M.S. Cheng, J.S. Rosa Duque, J.H.Y. Lam, and
S.M. Chan validated the data. J.S.R. Duque, G.T. Chua, K.N. Cheong,
E.Y.L. Au, J.S.Y. Kwok, P.C.Y. Chong, P.P.W. Lee, M.H.K. Ho, T.L. Lee,
and Y.L. Lau provided clinical care. D. Leung wrote the first draft
supervised by Y.L. Lau, with input from J.S. Rosa Duque, X. Mu, and
S.M.S. Cheng. All authors reviewed and approved the final
manuscript.